But because the landscape around compounded GLP-1 medications has shifted dramatically since the FDA resolved the semaglutide shortage in February 2025, and what was once a straightforward decision now involves regulatory gray areas, legal battles, and quality control questions that most people never expected to navigate
the 50% no follow-up monitoring gap - referenced from Episode 1] Our Sponsors: * Check out Chilipad and use my code BBM for a great deal: * Check out CovePure and use my code CovePure.com/bbm for a great deal: * Check out FIGS: * Check out Factor and use my code factormeals.com/bbm50off for a great deal: * Check out Quince and use my code quince.com/BBM for a great deal: Advertising Inquiries: 1m - Apr 28, 2026 Direct Line April 2026: Stopping Ozempic and Lifting With Osteopenia Stop a GLP-1 and about two thirds of the weight loss comes back within a year
If you are considering glutathione for cosmetic purposes, consult a qualified doctor or dermatologist first
Tirzepatides dual agonist mechanism may accelerate progress, with some people reporting accelerated weight drops during the second month especially at doses above 10 mg (Journal of Clinical Medicine Research)
It is the active pharmaceutical ingredient in Eli Lillys Mounjaro (FDA-approved 2022 for Type 2 diabetes) and Zepbound (FDA-approved 2023 for chronic weight management in adults with obesity or overweight with comorbidities, and 2024 for moderate-to-severe obstructive sleep apnea in adults with obesity)
While individual cases of increased suicidality following GLP-1 receptor agonist use have been reported, our large cohort study found no such association and instead suggested a decreased risk of suicidal behavior in adolescents receiving this treatment, Kerem told Healio